Evolus, Inc. (EOLS) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evolus, Inc. Common Stock.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.196 Good afternoon, everyone, and thank you for standing by. 00:00:03.196 -- 00:00:07.061 Welcome to Ebolus' first quarter earnings conference call. 00:00:07.061 -- 00:00:11.207 If anyone requires operator assistance during the conference, please press star zero 00:00:11.207 -- 00:00:16.315 or your telephone keypad. As a reminder, today's conference is being recorded and webcast 00:00:16.315 -- 00:00:19.960 live. All participants are in a listen-only mode. 00:00:19.960 -- 00:00:23.845 After the speaker's remarks, there will be a question-and-answer session. 00:00:23.845 -- 00:00:28.833 I would now like to turn the conference over to Narek Iskeren, Vice President, Head of 00:00:28.833 -- 00:00:31.714 Investor Relations, Corporate Communications. 00:00:31.714 -- 00:00:33.954 Please go 00:00:34.257 -- 00:00:34.657 ahead. 00:00:34.397 -- 00:00:39.082 Thank you, Operator, and welcome to everyone joining us on today's call to review Evelis' 00:00:39.082 -- 00:00:41.725 first quarter financial results. 00:00:41.725 -- 00:00:46.210 Our first quarter press release is now on our website at evelis.com. 00:00:46.210 -- 00:00:51.596 With me today are David Modizzetti, President and Chief Executive Officer, Tatiana Mitchell, 00:00:51.596 -- 00:00:56.782 Chief Financial Officer, and Rui Avalar, Chief Medical Officer and Head of R&D 00:00:56.782 -- 00:01:00.072 is also with us for the Q&A portion of the call. 00:01:00.072 -- 00:01:03.157 Today's call will include forward-looking statements. 00:01:03.157 -- 00:01:07.805 Actual results may differ materially due to risks and uncertainties outlined in our earnings 00:01:07.805 -- 00:01:12.633 press release and SEC filings. These forward-looking statements are based on current 00:01:12.633 -- 00:01:17.080 ...